Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
2.450
-0.060 (-2.39%)
Apr 1, 2025, 3:59 PM EDT - Market closed

Alpha Tau Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
9.029.2611.252.341.7
Upgrade
Research & Development
27.0226.4220.8911.457.54
Upgrade
Operating Expenses
36.0435.6832.1413.799.24
Upgrade
Operating Income
-36.04-35.68-32.14-13.79-9.24
Upgrade
Interest Expense
-0.3-0.08---
Upgrade
Interest & Investment Income
4.284.831.790.210.61
Upgrade
Currency Exchange Gain (Loss)
0.11-0.210.41-0.410.1
Upgrade
Other Non Operating Income (Expenses)
0.221.99-3.81-13.27-0.19
Upgrade
Pretax Income
-31.74-29.14-33.74-27.26-8.72
Upgrade
Income Tax Expense
0.010.020.020.010.16
Upgrade
Earnings From Continuing Operations
-31.75-29.16-33.76-27.27-8.88
Upgrade
Net Income
-31.75-29.16-33.76-27.27-8.88
Upgrade
Net Income to Common
-31.75-29.16-33.76-27.27-8.88
Upgrade
Shares Outstanding (Basic)
7069644140
Upgrade
Shares Outstanding (Diluted)
7069644140
Upgrade
Shares Change (YoY)
0.79%9.20%56.74%0.65%19.10%
Upgrade
EPS (Basic)
-0.45-0.42-0.53-0.67-0.22
Upgrade
EPS (Diluted)
-0.45-0.42-0.53-0.67-0.22
Upgrade
Free Cash Flow
-22.02-24.36-24.78-14.74-11.02
Upgrade
Free Cash Flow Per Share
-0.32-0.35-0.39-0.36-0.27
Upgrade
EBITDA
-34.94-34.61-31.16-13.01-9.16
Upgrade
D&A For EBITDA
1.11.070.980.780.09
Upgrade
EBIT
-36.04-35.68-32.14-13.79-9.24
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q